Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload

Pediatric Transplantation

Volumn 16, Issue 3, 2012, Pages

  Buchbinder, David ^a   Nugent, Diane ^a   Vu, Dan ^a   Soni, Amit ^a   Stites, Jill ^a   Hsieh, Loan ^a   Puthenveetil, Geetha ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

bone marrow transplant; deferasirox; deferoxamine; HEMPAS; iron chelation

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFERASIROX; DEFEROXAMINE; FERRITIN; FLUDARABINE; HLA ANTIGEN; HYDROXYUREA; IMMUNOGLOBULIN; MESNA; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MICAFUNGIN; PHENYTOIN; PREDNISONE; THIOTEPA; URSODEOXYCHOLIC ACID;

ARTICLE; BACTEREMIA; BONE MARROW EXAMINATION; BRONCHOSCOPY; CASE REPORT; CENTRAL VENOUS CATHETER; CHELATION THERAPY; CHILD; CHOLECYSTECTOMY; CHOLELITHIASIS; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 2; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE INCREASE; DYSERYTHROPOIESIS; ERYTHROBLAST; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HEARING IMPAIRMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HLA MATCHING; HUMAN; IRON CHELATION; IRON OVERLOAD; LAPAROSCOPIC SURGERY; LIVER BIOPSY; LIVER FIBROSIS; LOW DRUG DOSE; LUNG LAVAGE; MALE; MAXILLARY SINUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PROPHYLAXIS; RASH; SCHOOL CHILD; SIDEROSIS; SINUSITIS; SKIN BIOPSY; SPLENECTOMY; THROMBOCYTOSIS;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BENZOIC ACIDS; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; TRIAZOLES; UNRELATED DONORS;

EID: 84859723792     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01414.x     Document Type: Article

References (16)

1. Renella R, Wood WG,. The congenital dyserythropoietic anemias. Hematol Oncol Clin North Am 2009: 23: 283-306.
2. Heimpel H,. Congenital dyserythropoietic anemias: Epidemiology, clinical significance, and progress in understanding their pathogenesis. Ann Hematol 2004: 83: 613-621.
3. Goede JS, Benz R, Fehr J, Schwarz K, Heimpel H,. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy. Ann Hematol 2006: 85: 591-595.
4. Iolascon A, Delaunay J, Wickramasinghe SN, et al., Natural history of congenital dyserythropoietic anemia type II. Blood 2001: 98: 1258-1260.
5. Iolascon A, Sabato V, De Mattia D, Locatelli F,. Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant 2001: 27: 213-215.
6. Remacha AF, Badell I, Pujol-Moix N, et al., Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 2002: 100: 356-358.
7. Ayas M, Al-Jefri A, Baothman A, et al., Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. Bone Marrow Transplant 2002: 29: 681-682.
8. Ariffin WA, Karnaneedi S, Choo KE, et al., Congenital dyserytroipoietic anaemia: Report of three cases. J Paediatr Child Health 1996: 32: 191.
9. Capellini MD, Cohen A, Piga A, et al., A phase 3 study of defersirox (ICL 670), a once daily oral iron chelator in patients with beta-thalassemia. Blood 2006: 107: 3455-3462.
10. ClinicalTrials.gov: A Service of the National Institutes of Health. Combo Chelation Trail. Available at: (accessed May 22, 2010).
11. Lucarelli G, Galimberti M, Polchi P, et al., Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990: 322: 417-421.
12. Mathews V, George B, Lakshmi KM, et al., Impact of pretransplant splenectomy on patients with β-thalassemia major undergoing a matched-related allogeneic stem cell transplantation. Pediatr Transplant 2008: 13: 171-176.
13. Sodani P, Gaziev D, Polchi P, et al., New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004: 104: 1201-1203.
14. Gaziev J, Sodani P, Polchi P, et al., Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Ann N Y Acad Sci 2005: 1054: 196-205.
15. La NG, Giardini C, Argiolu F, et al., Unrelated donor bone marrow transplantation for thalassemia: The effect of extended haplotypes. Blood 2002: 99: 4350-4356.
16. La NG, Argiolu F, Giardini C, et al., Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005: 1054: 186-195.